Number of U.S. clinical-stage NCE programs by cardiovascular indications 2020
As of 2020, there were 25 clinical-stage new chemical entry programs for dyslipidemia in the United States, and 23 clinical-stage new chemical entry programs for congestive heart failure. This statistic illustrates the number of clinical-stage NCE programs in the United States, by cardiovascular indication.